XTX Topco’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

XTX Topco’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-702	Closed	-$222K	–	2472
2023 Q4	$222K	Sell	702 -2,917	-81%	-$567K	0.05%	875
2023 Q3	$612K	Buy	3,619 +1,593	+79%	+$300K	0.1%	279
2023 Q2	$439K	Buy	+2,026	New	+$434K	0.08%	453

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

XTX Topco's KRTX Position: Q1 2024 in Review

XTX Topco sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 702 shares — an estimated $222K sold.

XTX Topco first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $612K in Q3 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

XTX Topco reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
XTX Topco sold 702 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $222K.
XTX Topco first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
XTX Topco's Karuna Therapeutics, Inc. Common Stock position peaked at $612K in Q3 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on XTX Topco's 13F filing for Q1 2024, filed 13 May 2024.